240 related articles for article (PubMed ID: 23063435)
1. Genetic deletion of RALA and RALB small GTPases reveals redundant functions in development and tumorigenesis.
Peschard P; McCarthy A; Leblanc-Dominguez V; Yeo M; Guichard S; Stamp G; Marshall CJ
Curr Biol; 2012 Nov; 22(21):2063-8. PubMed ID: 23063435
[TBL] [Abstract][Full Text] [Related]
2. Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells.
Lim KH; O'Hayer K; Adam SJ; Kendall SD; Campbell PM; Der CJ; Counter CM
Curr Biol; 2006 Dec; 16(24):2385-94. PubMed ID: 17174914
[TBL] [Abstract][Full Text] [Related]
3. Ras-related small GTPases RalA and RalB regulate cellular survival after ionizing radiation.
Kidd AR; Snider JL; Martin TD; Graboski SF; Der CJ; Cox AD
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):205-12. PubMed ID: 20619549
[TBL] [Abstract][Full Text] [Related]
4. Contributions of KRAS and RAL in non-small-cell lung cancer growth and progression.
Guin S; Ru Y; Wynes MW; Mishra R; Lu X; Owens C; Barn AE; Vasu VT; Hirsch FR; Kern JA; Theodorescu D
J Thorac Oncol; 2013 Dec; 8(12):1492-501. PubMed ID: 24389431
[TBL] [Abstract][Full Text] [Related]
5. Divergent roles of CAAX motif-signaled posttranslational modifications in the regulation and subcellular localization of Ral GTPases.
Gentry LR; Nishimura A; Cox AD; Martin TD; Tsygankov D; Nishida M; Elston TC; Der CJ
J Biol Chem; 2015 Sep; 290(37):22851-61. PubMed ID: 26216878
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of RalA signaling pathway in treatment of non-small cell lung cancer.
Male H; Patel V; Jacob MA; Borrego-Diaz E; Wang K; Young DA; Wise AL; Huang C; Van Veldhuizen P; O'Brien-Ladner A; Williamson SK; Taylor SA; Tawfik O; Esfandyari T; Farassati F
Lung Cancer; 2012 Aug; 77(2):252-9. PubMed ID: 22498113
[TBL] [Abstract][Full Text] [Related]
7. RalA and RalB: antagonistic relatives in cancer cell migration.
Oxford G; Owens CR; Titus BJ; Foreman TL; Herlevsen MC; Smith SC; Theodorescu D
Cancer Res; 2005 Aug; 65(16):7111-20. PubMed ID: 16103060
[TBL] [Abstract][Full Text] [Related]
8. Ral isoforms are implicated in Fc gamma R-mediated phagocytosis: activation of phospholipase D by RalA.
Corrotte M; Nyguyen AP; Harlay ML; Vitale N; Bader MF; Grant NJ
J Immunol; 2010 Sep; 185(5):2942-50. PubMed ID: 20679536
[TBL] [Abstract][Full Text] [Related]
9. The RAL Enigma: Distinct Roles of RALA and RALB in Cancer.
Richardson DS; Spehar JM; Han DT; Chakravarthy PA; Sizemore ST
Cells; 2022 May; 11(10):. PubMed ID: 35626682
[TBL] [Abstract][Full Text] [Related]
10. KRAS oncogene substitutions in Korean NSCLC patients: clinical implication and relationship with pAKT and RalGTPases expression.
Kim EY; Kim A; Kim SK; Kim HJ; Chang J; Ahn CM; Lee JS; Shim HS; Chang YS
Lung Cancer; 2014 Aug; 85(2):299-305. PubMed ID: 24863005
[TBL] [Abstract][Full Text] [Related]
11. Tissue-specific expression of GTPas RalA and RalB during embryogenesis and regulation by epithelial-mesenchymal interaction.
Zhao Z; Rivkees SA
Mech Dev; 2000 Oct; 97(1-2):201-4. PubMed ID: 11025226
[TBL] [Abstract][Full Text] [Related]
12. Involvement of RhoA and RalB in geranylgeranyltransferase I inhibitor-mediated inhibition of proliferation and migration of human oral squamous cell carcinoma cells.
Hamada M; Miki T; Iwai S; Shimizu H; Yura Y
Cancer Chemother Pharmacol; 2011 Sep; 68(3):559-69. PubMed ID: 21107573
[TBL] [Abstract][Full Text] [Related]
13. The small G-protein RalA promotes progression and metastasis of triple-negative breast cancer.
Thies KA; Cole MW; Schafer RE; Spehar JM; Richardson DS; Steck SA; Das M; Lian AW; Ray A; Shakya R; Knoblaugh SE; Timmers CD; Ostrowski MC; Chakravarti A; Sizemore GM; Sizemore ST
Breast Cancer Res; 2021 Jun; 23(1):65. PubMed ID: 34118960
[TBL] [Abstract][Full Text] [Related]
14. RalA but not RalB enhances polarized delivery of membrane proteins to the basolateral surface of epithelial cells.
Shipitsin M; Feig LA
Mol Cell Biol; 2004 Jul; 24(13):5746-56. PubMed ID: 15199131
[TBL] [Abstract][Full Text] [Related]
15. Characterization of RalB-Sec5-TBK1 function in human oncogenesis.
Chien Y; White MA
Methods Enzymol; 2008; 438():321-9. PubMed ID: 18413258
[TBL] [Abstract][Full Text] [Related]
16. Ral GTPase down-regulation stabilizes and reactivates p53 to inhibit malignant transformation.
Tecleab A; Zhang X; Sebti SM
J Biol Chem; 2014 Nov; 289(45):31296-309. PubMed ID: 25210032
[TBL] [Abstract][Full Text] [Related]
17. Expression of ral GTPases, their effectors, and activators in human bladder cancer.
Smith SC; Oxford G; Baras AS; Owens C; Havaleshko D; Brautigan DL; Safo MK; Theodorescu D
Clin Cancer Res; 2007 Jul; 13(13):3803-13. PubMed ID: 17606711
[TBL] [Abstract][Full Text] [Related]
18. Differential involvement of RalA and RalB in colorectal cancer.
Martin TD; Der CJ
Small GTPases; 2012; 3(2):126-30. PubMed ID: 22790202
[TBL] [Abstract][Full Text] [Related]
19. Expression profiling of Ral-depleted bladder cancer cells identifies RREB-1 as a novel transcriptional Ral effector.
Oxford G; Smith SC; Hampton G; Theodorescu D
Oncogene; 2007 Nov; 26(50):7143-52. PubMed ID: 17496927
[TBL] [Abstract][Full Text] [Related]
20. Ral GTPases in Schwann cells promote radial axonal sorting in the peripheral nervous system.
Ommer A; Figlia G; Pereira JA; Datwyler AL; Gerber J; DeGeer J; Lalli G; Suter U
J Cell Biol; 2019 Jul; 218(7):2350-2369. PubMed ID: 31201267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
